Psoriatic arthritis and HCV elimination from NZ (GP CME Rotorua)

In this review:

This publication is a summary of two presentations made at the Abbvie Breakfast Session on June 11 as part of the Rotorua GP CME 2016 meeting. Dr Doug White spoke on the role of primary healthcare providers in identifying patients with possible psoriatic arthritis early in their disease and making appropriate specialist referral for such patients, thereby improving time to diagnosis and patient care. Prof Ed Gane presented data on DAA (direct-acting antiviral) therapies and their ability to provide a cure for chronic HCV (hepatitis C virus) infection which is well tolerated. Importantly, these regimens are now available in NZ, and in combination with efforts to prevent disease transmission will be important in the elimination of HCV from NZ.

Download PDF Subscribe